Bixiye
P36-16 Case Management (T1016) Billing for Tuberculosis Related Services for Government Programs Subscribers
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2851 - 2860 ee natiijooyinka 3607
Bixiye
P60-16 New Drug-Related Prior Authorization Criteria with Quanatity Limit for Topical Diclofenac Gel, Fluorourcil Cream, Imquimod Cream and Ingenol Gel
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2016
Bixiye
P39-16 Expansion of Drug-Related Xenazine Prior Authorization Criteria with Quantity Limit to Minnesota Health Care Programs
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2016
Bixiye
P40-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Lidocaine Transdermal
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2016
Bixiye
P45R1-16 Update on New Drug, Ocrevus (ocrelizumab)
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2016
Bixiye
P45-16 A New Drug, Ocrevus (ocrelizumab) Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2016
Bixiye
P57-16 Change in Medical Policy and Commercial Benefit Coverage of CT Colonography Colorectal Cancer Screening Test
Taariikhda uu dhaqangalayo Barnaamijka: Nov 22, 2016
Bixiye
P37-16 Addition of a Drug (Epclusa) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2016
Bixiye
P24-17 AOR No Longer Required for Submission of Organization Determinations for Platinum Blue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 18, 2017
Bixiye
P11R1-17 Revised: Pre-Admission Notification Requirement for Admissions effective June 1, 2017
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2017